Self-Insurance Bill Passes House Vote

The House on Wednesday passed a bill that could protect and keep costs down for small and mid-sized self-insured employers.

The Self-Insurance Protection Act, which passed with a 400-16 vote, would prohibit state insurance regulators from overseeing these health plans by excluding medical stop-loss policies. All 260 Republicans who voted supported passage and only 16 Democrats opposed passage.

The legislation would amend the Employee Retirement Income Security Act, the Public Health Service Act and the Internal Revenue Code to clarify that federal regulators cannot redefine stop-loss insurance as traditional health insurance, ensuring that employers can continue to utilize the financial risk-management tool when offering employees healthcare coverage through a self-funded plan.

“It’s a preemptive play to prevent regulatory overreach in our view,” says Mike Ferguson, CEO of Self-Insurance Institute of America, a trade group for companies in the self-insurance marketplace. “We feel it’s important to go ahead and get this clarified now.”

The Obama administration, Ferguson says, saw stop-loss carriers as health insurers because they were bearing the risk. Thus, self-insured employers could be considered fully insured entities and be brought under the ACA umbrella, which would subject them to the medical loss ratio and the Cadillac tax, under an aggressive interpretation of the statute.

Without protections, stop-loss carriers would stop offering those policies, leaving employers in the lurch if they get hit with catastrophic claims.

“They don’t want to be conflated with health insurers,” says Ferguson.

Proponents are also hopeful that the legislation will help employers in their ongoing struggle to slow the growth of health benefit costs.

“By protecting access to self-insurance, we can help ensure employers have the tools they need to control healthcare costs for working families,” Rep. Phil Roe (R-Tenn.), who introduced the bill, said in a statement. “Millions of Americans rely on flexible self-insured plans and the benefits they provide. This legislation prevents bureaucratic overreach and represents an important step toward promoting choice in healthcare.”

Source Link

 

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square